Characterization of non-neoplastic and malignant human stem cell populations in their native state can provide new insights into gliomagenesis. Here we developed a purification strategy to directly isolate EGFR +/À populations from human germinal matrix (GM) and adult subventricular zone autopsy tissues, and from de novo glioblastoma ( 
INTRODUCTION
Glioblastoma (GBM) is the most common and rapidly fatal adult brain tumor. Several developmental pathways important for the growth and proliferation of normal neural progenitors have been shown to be aberrantly reactivated in GBM and glioma stem cells (Canoll and Goldman, 2008; Chen et al., 2012; Lathia et al., 2015; Sanai et al., 2005) , through complex genetic and emerging epigenetic alterations (Flavahan et al., 2016; Mack et al., 2015) . Among these is the epidermal growth factor receptor (EGFR) pathway, with activating EGFR genomic alterations defining the most common ''classical'' GBM molecular signature (Brennan et al., 2013; Verhaak et al., 2010) and chromatin remodeling at its promoter driving EGFR overexpression (Erfani et al., 2015) . EGFR is also highly expressed in the human developing germinal matrix (GM), as well as focally in the infant and adult subventricular zone (SVZ) (Erfani et al., 2015; Sanai et al., 2011; Weickert et al., 2000) , but the stem cell properties and molecular characteristics of human EGFR-positive ( cells (2 hr after FACS) shows predominant distribution of EGFR in the positive fraction (93%) (**p = 0.002), and comparable expression of SOX2 and Ki67 in both fractions (n = 3 independent experiments) (see also Figure S2G ). (D) Representative primary NS growth at 6 days.
(E and F) Quantification of primary NS growth (n = 12 independent experiments; ***p = 2.9 3 10
À5
) and (F) NS size (n = 5 independent experiments; **p = 0.01) at 6 days (EGF + FGF Figure S2F ). EGFR expression was maintained during NS passaging, including in clonal NS derived from single-cell seeding (1 cell/well) ( Figure S1G ). Under differentiation conditions, only EGFR + GM-derived NS showed potential for tri-lineage differentiation ( Figures 1G and S2D ). In contrast, EGFR
showed little or no NS proliferation, and lacked the capacity for self-renewal in serial passaging ( Figures 1D-1F , S2D, and S2E). We also studied the properties of EGFR + cells in the infant and adult human SVZ. Immunofluorescence revealed focal and weaker EGFR expression in the postnatal SVZ in vivo, with drastic decline in Ki67 cell-cycle labeling (Figures S1H, S2B, and S2C), consistent with previous reports (Erfani et al., 2015; Sanai et al., 2011 GBM samples also exhibit stem cell properties in vitro, we employed the same isolation methodology and culture conditions used for normal neural tissues. All GBM samples were de novo resections, with different genomic alterations, including EGFR amplification and/or chromosome 7 polysomy, EGFRvIII mutation, and isocitrate dehydrogenase 1 (IDH1) mutation (Table S1 ). In vivo analysis of EGFR expression in these GBM samples revealed widespread expression of its intracellular domain (EGFR-ID) and more variable expression of its extracellular domain (EGFR-ED), consistent with EGFR-ED's focal loss in EGFRvIII and/or other truncating mutations ( Figure 2A ; Brennan et al., 2013 Figure 2E , n = 16), and were the only ones to show self-renewal in serial passaging ( Figures 2D and 2E ). In contrast, EGFR À DAPI À cells did not divide ( Figure S3B ) and EGFR À DAPI low cells divided initially in one sample only, but did not form GS even after 4 weeks of growth ( Figures 2D and 2E ). Importantly, populations from our exclusion channels, CD24-PE, CD34-PE, and CD45-PE, cultured under identical conditions, attached to the plate but did not proliferate into GS ( Figure S3D (Table S2 ). Expression of EGFR was maintained in clonogenic spheres (1 cell/well) ( Figure S1N ), and was upregulated in GS formed without exogenous EGF in the culture medium ( Figure S1O ). À cells (K) (n = 3 independent experiments; 12 days) (see also Figure S3C ). Scale bars, 50 mm. Magnification of GS images, 103. Bar graphs show mean ± SEM.
Of note, two GBM samples in our study did not show any expression of EGFR, and thus also lacked a defined LB EGFR + population. In one of them, G-10416, GS formations were present in the EGFR À tumor population ( Figure S2L) while in the other, G-11702, GS were not formed (data not shown). Overall, the data indicate that for GBM tumors that express EGFR, with or without EGFR amplification/vIII mutation, EGF-based isolation enriches for LB EGFR + populations with in vitro stem cell properties.
Sphere-Forming Cells Are Fully Captured within LB EGFR + GBM Populations
To further validate our technique, we compared EGFbased FACS against several established glioma stem cell isolation markers, including CD133 (Prominin-1), CD171 (L1CAM), CD44, and CD140a (PDGFRA) (Anido et al., 2010; Bao et al., 2008; Flavahan et al., 2016; Singh et al., 2004 2K ; Beier et al., 2007) . No GS were present in EGFR À CD133 À cells ( Figure S3B ). Again, GS grew in similar numbers with and without the addition of exogenous EGF to the medium ( Figure S3C ). Similarly to CD133, LB EGFR + GBM cells were present within both positive and negative CD171, CD140a, and CD44 populations, encompassing all sphere-forming populations ( Figures S3E-S3G ). These results underscore the utility of our ligand-based methodology for the selective yet inclusive isolation of glioma cells with in vitro proliferative stem cell properties from fresh EGFR-expressing GBM tumors, capturing all sphere-forming populations. Figure 3C ) or no engraftment ( Figures 3D and 3E) . By 4-6 months, mice injected with LB EGFR + DAPI low cells exhibited large and diffusely infiltrative high-grade gliomas ( Figure 3F ), retaining the EGFR amplification status of their original resection ( Figure 3G ). The phenotype in the well-formed tumors at 4-6 months was less proliferative than at 2 months ( Figure 3B ), with expression of differentiating markers such as GFAP and TUJ1 (TUBB3) ( Figure 3H ), recapitulating human GBM heterogeneity ( Figures S1L and S1M) Figure 4B ). Differential gene set analysis revealed strong enrichment in pathways related to cell proliferation and mitotic cell cycle in both GM and GBM LB EGFR + populations ( Figures S4B-S4D and Table S3 ).
Further analysis defined subset of 50 developmentally regulated genes to be uniquely shared between human GBM and GM EGFR + populations, including several implicated in cell-cycle regulation: CENPE, DBF4, KPNA2, and KNSTRN ( Figures 4C-4E and Table S3 ). Together, our data provide functional and molecular evidence for stem cell properties in ligand-binding EGFR + cells during both neural development and in GBM.
DISCUSSION
Comparative analyses of non-neoplastic and neoplastic human neural populations, isolated ex vivo from fresh pathology samples, are technically challenging but can yield important insight into both normal biology and gliomagenesis. Here we provide a useful ligand-based methodology to purify EGFR + GM progenitors and GBM cells from fresh human tissues, and elaborate on their phenotypic, functional, and molecular comparative properties. Importantly, we discover that EGFR + GM and GBM populations encompass all sphere-forming cells in vitro, displaying self-renewal and multi-lineage differentiation stem cell properties, and that freshly isolated LB EGFR + GBM cells form high-grade and diffusely infiltrating gliomas by 4 months after orthotopic transplantation. We confirm that this ligand-based isolation strategy does not simply select for populations dependent on EGF ligand for growth, demonstrating the ability of LB EGFR + populations for sphere formation in vitro and tumor initiation in vivo in the absence of exogenous EGF ligand supplementation. Several important markers have been utilized to identify and characterize glioma stem cells (GCS) in fresh human GBM tissues and patient-derived neurosphere cultures, but many of them have not captured all sphere-forming cells in vitro (Lathia et al., 2015) . By combining our EGF ligand-based isolation methodology with CD133, CD140a, CD171, or CD44, we show that EGF ligand binding captures all GS-forming colonies. This underscores the transplants display large and diffusely infiltrative high-grade gliomas, (G) retain EGFR amplification status by chromogenic in situ hybridization, and (H) express EGFR as well as differentiating markers GFAP and TUJ1 (representative examples, n = 3 independent tumors for F-H). Scale bars, 50 mm. Bar graphs show mean ± SEM. ability of our EGF ligand-based isolation methodology to recapitulate the in vitro GSC phenotypes previously characterized by others, as well as to capture additional sphere-forming populations with potential functional and molecular significance.
Although GBM tumors with diffuse EGFR amplification displayed the most pronounced LB EGFR + population in FACS, we also captured all sphere-forming cells in EGFRexpressing GBM tumors without EGFR amplification (7 out of 19), one of which harbored IDH1 mutation. Thus, we believe this methodology will be useful for isolating stem cell populations in both EGFR-amplified ''classical'' and IDH1-mutant ''proneural'' GBM tumors, and perhaps others, as long as they express EGFR, but may not be applicable for occasional tumors that lack a defined LB EGFR + population. Given the bias of neurosphere assays and xenograft tumor initiation models for proliferation, our methodology is particularly useful for isolating populations with active, but not necessarily quiescent, stem cell properties.
The similarities between the transcriptome of GM and GBM LB EGFR + stem cell populations for markers of cell-cycle regulation suggest that the proliferative tumor phenotype of LB EGFR + GBM populations may be at least partially driven by co-opted transcriptional programs important for cell division during germinal matrix development (Flavahan et al., 2016; Liu et al., 2015; Mack et al., 2015; Suva et al., 2014; Tsankova and Canoll, 2014) . The interplay GM/GBM genes related to cell proliferation (n = 3 independent experiments). Plots show the median (black horizontal line), 25th and 75th percentiles (boxes), and range (whiskers) of the data. One-tailed unpaired Students' t test and Mann-Whitney U test for non-parametric test were used to calculate statistical significance (EGFR GM, *p = 0.024, GBM, **p = 0.007; DBF4 GM, *p = 0.023, GBM, *p = 0.046; ASCL1 GM, *p = 0.03, GBM, *p = 0.02; CENPE GM, *p = 0.039; KPNA2 GM, *p = 0.04; KNSTRN GM, *p = 0.02).
between genomic alterations and developmental remodeling of transcriptional networks in tumor cells is an intriguing question to be explored in future studies, and to this end we have here validated a useful and clinically relevant methodology for the prospective isolation of neural and GBM populations with proliferative stem cell properties.
EXPERIMENTAL PROCEDURES
Detailed methods are provided in Supplemental Experimental Procedures.
Sample Collection
All specimen collection was performed de-identified in accordance with the policies and regulation at the Icahn School of Medicine at Mount Sinai (ISMMS) and its institutional review board (IRB#AAAJ9652-Y1M00, HS#14-01007).
Fluorescence-Activated Cell Sorting
Single-cell suspension was obtained from fresh tissue (dissected GM/SVZ autopsy or GBM surgical material) by mechanical and enzymatic papain dissociation, and incubated with EGF-Alexa Fluor 647(APC) complex for positive selection of EGFR cells (1 mg per 10 6 live cells), and with CD24/CD34/CD45 antibodies and DAPI for exclusions (Codega et al., 2014) .
Cell Culture
Cells were cultured on 96-well low-adherence plates in freshly made NS medium (see recipe in Supplemental Experimental Procedures), with addition of EGF (20 ng/mL) and/or basic FGF (bFGF) (20 ng/mL), or with no ligand, at a density of 10 cells/mL or 1 cell/mL (for 1 or 2 NS/GS formation, respectively). For ELDA, acutely sorted cells were seeded at 1, 10, 50, and 100 cells/well. For differentiation, NS/GS were seeded on PDL/laminin-coated coverslips and grown in NS medium without B27, EGF, and bFGF for 14 days.
Orthotopic Transplantation
Mouse studies were performed in accordance with the Institutional Animal Care and Use Committee (IACUC), protocol number IACUC-2014-0183. Acutely FACS-sorted cells (0.5-1 3 10 5 ) from fresh GBM samples were injected into the striatum of 2-monthold SCID male mice (2 mm right lateral to bregma and 3 mm deep). Mice were euthanized for histological examination of tumor initiation at 60 days and of endpoint tumor formation when clinically symptomatic.
Gene Expression Analysis
Whole-transcriptome analysis was performed by RNA-seq on RNA extracted from freshly FACS-sorted EGFR +/À GBM and GM cells (125 bp pair-end sequencing, 38-50 million paired-end reads/sample, on Illumina HiSeq 2500). cDNA was generated using Clontech SMART-seq v4 (634888) and libraries using Nextera XT (FC-131-1024). The expression of selected genes was validated by qRT-PCR.
Immunofluorescence
Floating vibratome sections (40-60 mm), formalin-fixed paraffinembedded (FFPE) sections (4 mm), NS/GS, and acutely fixed FACS-sorted cells were blocked in 10% normal donkey serum for 0.5-1 hr, incubated with primary antibody overnight at 4 C, incubated with secondary antibodies for 2-4 hr at room temperature, and visualized on a confocal Zeiss LSM710 microscope. Modified protocols were used for EGFR and O4 staining (see Supplemental Experimental Procedures).
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